Cargando…
Optimization of Drug Delivery by Drug-Eluting Stents
Drug-eluting stents (DES), which release anti-proliferative drugs into the arterial wall in a controlled manner, have drastically reduced the rate of in-stent restenosis and revolutionized the treatment of atherosclerosis. However, late stent thrombosis remains a safety concern in DES, mainly due to...
Autores principales: | Bozsak, Franz, Gonzalez-Rodriguez, David, Sternberger, Zachary, Belitz, Paul, Bewley, Thomas, Chomaz, Jean-Marc, Barakat, Abdul I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470631/ https://www.ncbi.nlm.nih.gov/pubmed/26083626 http://dx.doi.org/10.1371/journal.pone.0130182 |
Ejemplares similares
-
Drug Release Analysis and Optimization for Drug-Eluting Stents
por: Li, Hongxia, et al.
Publicado: (2013) -
Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019) -
Local drug-delivery balloon for proliferative occlusive in-stent restenosis after drug-eluting stent
por: Rigatelli, Gianluca, et al.
Publicado: (2011) -
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013) -
Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
por: Gherasie, Flavius-Alexandru, et al.
Publicado: (2023)